LENSAR (NASDAQ:LNSR – Get Free Report) will be announcing its earnings results before the market opens on Thursday, November 7th. Persons interested in listening to the company’s earnings conference call can do so using this link.
LENSAR (NASDAQ:LNSR – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.53) EPS for the quarter. LENSAR had a negative return on equity of 30.69% and a negative net margin of 27.83%. The firm had revenue of $12.64 million during the quarter.
LENSAR Stock Up 2.4 %
LNSR stock traded up $0.14 during trading on Tuesday, reaching $6.00. The stock had a trading volume of 14,714 shares, compared to its average volume of 32,390. The stock’s 50 day moving average is $4.87 and its two-hundred day moving average is $4.51. LENSAR has a 52 week low of $1.80 and a 52 week high of $6.25.
LENSAR Company Profile
LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
Read More
- Five stocks we like better than LENSAR
- Pros And Cons Of Monthly Dividend Stocks
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Consumer Staples Stocks, Explained
- Insider Buying Signals Upside for These 3 Stocks
- Using the MarketBeat Dividend Tax Calculator
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.
